chemical repair

chem·i·cal re·pair

conversion of a free radical to a stable molecule.

chem·i·cal re·pair

(kem'i-kăl rĕ-pār')
Conversion of a free radical to a stable molecule.
References in periodicals archive ?
Slavica's primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C.
The company, which is divided into three divisions: Thortex, which provides metal, ceramic and chemical repair systems plus floor and wall protection systems; Copon, which specialises in high performance protective coatings and pipelinings; and ThistleBond, specialising in repair and maintenance products for the marine sector, exports to no less than 85 countries.
E Wood was formed in London in 1882 and now has three divisions - Thortex, which provides metal, ceramic and chemical repair systems plus floor and wall protection systems; Copon, which specialises in high performance protective coatings and pipelinings; and ThistleBond, specialising in repair and maintenance products for the marine sector.
Located in Serbia, Slavica's primary focus involves the enhancement and modification of existing approved drugs to achieve chemical repair of damage to the CNS (central nervous system) by diseases like MS (Multiple Sclerosis), SARS, Hepatitis C and HIV.
The European companies we have examined are currently focused on the chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis) SARS, Hepatitis C, HIV through the enhancement of already approved drugs such as "Virazole" and Tiazofurin.
As well, the company in the unlikely event of a non completion with the China based medical company is also continuing its negotiations with an East European medical company whose primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV.
In Serbia the company's primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV.
Full browser ?